Cargando…

The renoprotective effect of concomitant fosfomycin in the treatment of pulmonary exacerbations in cystic fibrosis

BACKGROUND: Fosfomycin, effective in Cystic Fibrosis (CF), competes with aminoglycosides at renal binding sites and may therefore afford a renoprotective effect when used in combination therapy. We explored this by using markers of acute renal tubular damage [N-acetyl-β-d-glucose-aminidase (NAG), al...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Aloul, Mohamed, Nazareth, Dilip, Walshaw, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Kidneyand Extrarenal Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768307/ https://www.ncbi.nlm.nih.gov/pubmed/31583092 http://dx.doi.org/10.1093/ckj/sfz005

Ejemplares similares

Inflammatory bowel disease in patients undergoing renal biopsies
por: Pohjonen, Jussi, et al.
Publicado: (2019)

Mycobacterium Simiae Infection in a Person With Cystic Fibrosis
por: FitzMaurice, Thomas S, et al.
Publicado: (2020)

Case Report: Haemolytic anaemia with ceftazidime use in a patient with cystic fibrosis
por: Yong, Jun, et al.
Publicado: (2018)

Cystic fibrosis-related diabetes: optimizing care with a multidisciplinary approach
por: Frost, Freddy, et al.
Publicado: (2019)

Cardiac sarcoidosis in an adult person with cystic fibrosis: a case report
por: FitzMaurice, Thomas Simon, et al.
Publicado: (2022)

Developing an ecological approach to physical activity promotion in adults with Cystic fibrosis
por: Shelley, James, et al.
Publicado: (2022)

P094 Facilitating cystic fibrosis research during the COVID-19 pandemic
por: Burnett, S., et al.
Publicado: (2021)

Evaluation of the Risk for Acute Kidney Injury in Adult Cystic Fibrosis Patients Receiving Concomitant Vancomycin and Tobramycin
por: Muirhead, Corinne, et al.
Publicado: (2017)

Prevalence, risk factors and outcomes of cardiac disease in cystic fibrosis: a multinational retrospective cohort study
por: Frost, Freddy, et al.
Publicado: (2023)

P086 The impact of COVID-19 in people with cystic fibrosis – a single-centre experience
por: Aldous, G., et al.
Publicado: (2021)

Feasibility of dynamic chest radiography to calculate lung volumes in adult people with cystic fibrosis: a pilot study
por: FitzMaurice, Thomas Simon, et al.
Publicado: (2023)

Acute hyperglycaemia in cystic fibrosis pulmonary exacerbations
por: Merjaneh, Lina, et al.
Publicado: (2020)

P139 Evaluating the impact of a telemedicine service during the COVID-19 pandemic in people with cystic fibrosis
por: Bull, A., et al.
Publicado: (2021)

Utility and validity of dynamic chest radiography in cystic fibrosis (dynamic CF): an observational, non-controlled, non-randomised, single-centre, prospective study
por: FitzMaurice, Thomas Simon, et al.
Publicado: (2020)

Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis
por: Sawant, Akhil, et al.
Publicado: (2018)

Evaluation of Copeptin during Pulmonary Exacerbation in Cystic Fibrosis
por: Wojsyk-Banaszak, I., et al.
Publicado: (2019)

Lung ultrasound for the diagnosis of cystic fibrosis pulmonary exacerbation
por: Hassanzad, Maryam, et al.
Publicado: (2021)

P090 A UK survey on changes in managing people with cystic fibrosis during the COVID-19 pandemic
por: Hameed, M.S., et al.
Publicado: (2021)

ePS4.08 COVID-19 vaccine uptake in adult people with cystic fibrosis
por: Mir, M.H., et al.
Publicado: (2022)

Glucose Tolerance during Pulmonary Exacerbations in Children with Cystic Fibrosis
por: Widger, John, et al.
Publicado: (2012)

Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis
por: DiMango, Emily, et al.
Publicado: (2014)

Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations
por: Zemanick, Edith T., et al.
Publicado: (2013)

Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations
por: Skolnik, Kate, et al.
Publicado: (2018)

Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis
por: Asner, Sandra, et al.
Publicado: (2012)

Case Report: First report of Elizabethkingia miricola infection in a patient with cystic fibrosis
por: Frost, Freddy, et al.
Publicado: (2018)

BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis
por: Schultz, Andre, et al.
Publicado: (2023)

Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study
por: Wells, J. Michael, et al.
Publicado: (2016)

Pulmonary Exacerbations in Adults With Cystic Fibrosis: A Grown-up Issue in a Changing Cystic Fibrosis Landscape
por: Stanford, Gemma E., et al.
Publicado: (2021)

Change in circulating proteins during treatment of pulmonary exacerbation in patients with cystic fibrosis
por: Wagner, Brandie D., et al.
Publicado: (2021)

Association between respiratory and herpes viruses on pulmonary exacerbations in cystic fibrosis patients
por: Scheithauer, Simone, et al.
Publicado: (2010)

Metabolomics of pulmonary exacerbations reveals the personalized nature of cystic fibrosis disease
por: Quinn, Robert A., et al.
Publicado: (2016)

Clinical impact of respiratory virus in pulmonary exacerbations of children with Cystic Fibrosis
por: Meyer, Viviane Mauro Correa, et al.
Publicado: (2020)

Azithromycin and Tobramycin Therapy in Cystic Fibrosis Pulmonary Exacerbations: Less Is More?
por: Thornton, Christina, et al.
Publicado: (2021)

Lung Clearance Index in Children with Cystic Fibrosis during Pulmonary Exacerbation
por: Walicka-Serzysko, Katarzyna, et al.
Publicado: (2021)

Two Steps Forward: Improving the Management of Cystic Fibrosis Pulmonary Exacerbations
por: Waters, Valerie
Publicado: (2021)

Identification and characterization of bacteria isolated from patients with cystic fibrosis in Jordan
por: Alshraiedeh, Nid’a, et al.
Publicado: (2022)

Home intravenous antibiotic treatment for acute pulmonary exacerbations in cystic fibrosis — Is it good for the patient?
por: Sequeiros, Iara Maria, et al.
Publicado: (2009)

1315. Ceftaroline Versus Vancomycin for the Treatment of Acute Pulmonary Exacerbations of Cystic Fibrosis in Adults
por: Esquivel, Marc, et al.
Publicado: (2021)

Can Identifying Pulmonary Exacerbation Phenotypes Guide New Treatment Approaches for Cystic Fibrosis?
por: Caverly, Lindsay J.
Publicado: (2022)

Acute exacerbation of idiopathic pulmonary fibrosis: a 10-year single-centre retrospective study
por: Yamazoe, Masatoshi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_je91hpvek62u0l999okgoe4g6m